🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Anke Hemmerling

University of California, San Francisco

ORCID: 0000-0002-6472-4804

Also affiliated with University of San Francisco

Immunology and MicrobiologyBiochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 12 papers. Top paper: “Metronidazole treatment rapidly reduces genital inflammation through effects on bacterial vaginosis–associated bacteria rather than lactobacilli”.

Metronidazole treatment rapidly reduces genital inflammation through effects on bacterial vaginosis–associated bacteria rather than lactobacilli

Journal of Clinical Investigation(2022)10.1172/jci152930

N/A

1.9DataRank · unranked

46 citations

Anke Hemmerling, Steve Miller, Kerianne E. Burke, Sara J. Newmann, Sheldon R. Morris +11 more

Vaginal fungi are associated with treatment-induced shifts in the vaginal microbiota and with a distinct genital immune profile

Microbiology Spectrum(2024)10.1128/spectrum.03501-23

N/A

0.472DataRank · unranked

12 citations

Anke Hemmerling, Steve Miller, Sanja Huibner, Maria Kulikova, Rachel Liu +6 more

Bridging the gap: advancing multipurpose prevention technologies from the lab into the hands of women†

Biology of Reproduction(2020)10.1093/biolre/ioaa085

N/A

0DataRank · unranked

12 citations

James Kiarie, Gregory S. Kopf, Kavita Nanda, Anke Hemmerling, Sharon L. Achilles +1 more

Sustained effect of LACTIN-V (Lactobacillus crispatus CTV-05) on genital immunology following standard bacterial vaginosis treatment: results from a randomised, placebo-controlled trial

The Lancet Microbe(2022)10.1016/s2666-5247(22)00043-x

N/A

0DataRank · unranked

78 citations

Anke Hemmerling, Steve Miller, Kerianne Burke, Sara J. Newmann, Sheldon Morris +8 more

Treatment Success Following Standard Antibiotic Treatment for Bacterial Vaginosis Is Not Associated With Pretreatment Genital Immune or Microbial Parameters

Open Forum Infectious Diseases(2023)10.1093/ofid/ofad007

N/A

0DataRank · unranked

11 citations

Anke Hemmerling, Vineet Joag, Sanja Huibner, Maria Kulikova, Emily Crawford +9 more

Expanding the pipeline for multipurpose prevention technologies: compounds with potential activity to prevent or treat HIV and other STIs

Sexually Transmitted Infections(2023)10.1136/sextrans-2022-055647

N/A

0DataRank · unranked

3 citations

Anke Hemmerling, Susanna Moore, Katherine Yang, Bethany Young Holt

Vaginal Lactobacillus crispatus persistence following application of a live biotherapeutic product: colonization phenotypes and genital immune impact

Microbiome(2024)10.1186/s40168-024-01828-7

N/A

0DataRank · unranked

20 citations

Anke Hemmerling, Steve Miller, Sanja Huibner, Maria Kulikova, Emily Crawford +5 more

Response to Antibiotic Treatment of Bacterial Vaginosis Predicts the Effectiveness of LACTIN-V (Lactobacillus crispatus CTV-05) in the Prevention of Recurrent Disease

Sexually Transmitted Diseases(2024)10.1097/olq.0000000000001962

N/A

0DataRank · unranked

12 citations

Michael R. Wierzbicki, Eric Armstrong, Craig R. Cohen, Anke Hemmerling

Editorial: Multipurpose prevention technologies: call for innovative strategies to address critical priorities and gaps

Frontiers in Reproductive Health(2024)10.3389/frph.2024.1417974

N/A

0DataRank · unranked

4 citations

Ariane van der Straten, Anke Hemmerling, Jim A. Turpin, Bethany Young Holt, Clara Soh

Connecting the Dots: Translating the Vaginal Microbiome Into a Drug

The Journal of Infectious Diseases(2020)10.1093/infdis/jiaa676

N/A

0DataRank · unranked

51 citations

Anke Hemmerling, Charles Y. Chiu, Steve Miller, Peter P. Lee, Craig R. Cohen +2 more

Microbiota effects and predictors of Lactobacillus crispatu s colonization after treatment with a vaginal live biotherapeutic: results from a randomized, double-blinded, placebo-controlled trial

medRxiv(2025)10.1101/2025.08.18.25333897

N/A

0DataRank · unranked

0 citations

Laura Symul, Joseph Elsherbini, Jiawu Xu, Salina Hussain, Johnathan Shih +10 more

Towards a roadmap to advance non-hormonal contraceptive multipurpose prevention technologies: strategic insights from key stakeholders†

Biology of Reproduction(2020)10.1093/biolre/ioaa092

N/A

0DataRank · unranked

16 citations

Emily Christopher, Bethany Young Holt, Anke Hemmerling